Clin2
NCT06798350Possibly a fitNot yet recruiting

Inflammation markers in men with mild erectile problems

Erectile Dysfunction, CTCAE

Part of Kidney & urinary, Mental health clinical trials.

This study looks at how inflammation in the body relates to erectile dysfunction. Researchers want to see if certain inflammatory markers in the blood differ between men with mild erectile issues and healthy men, which could lead to better understanding and treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are a man between 18 and 55 years old.
  • You have regular sexual activity.
  • You have completed an erectile function questionnaire (IIEF-5) with a score of 22 or higher, meaning mild or no erectile problems.
  • You do not have spinal cord injury, neurological disease, severe heart disease, or penile fibrosis (scar tissue in the penis).
  • You are not currently taking PDE5 inhibitor medications (such as sildenafil or tadalafil) for erectile dysfunction.
  • You do not have hormone abnormalities, thyroid disease, Peyronie's disease, prostate or urinary tract infections, or poor REM sleep.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07773103Recruiting
Tadalafil and blood vessel markers for erectile dysfunction

This study tests whether tadalafil, a daily pill for erectile dysfunction, improves blood vessel health and erectile function. It may help men with erectile dysfunction caused by blood vessel problems.

Cairo
NCT07813195Not yet recruiting
Erectile dysfunction and heart disease severity in men

This study looks at whether the severity of erectile dysfunction (ED) is linked to how serious heart disease is in men who have a heart catheterization procedure. The goal is to see if ED could be a warning sign for heart problems.

NCT06996925Enrolling by invitation
Depression, illness beliefs, and erectile function

This study looks at how your feelings about your health and your mood may affect erectile dysfunction. It could help doctors understand the link between depression and erectile problems.

Istanbul
NCT06720597Recruiting
Testing a device for blood vessel health in erectile dysfunction

This study tests a device called EndoPAT to check how well the blood vessels in your penis are working. It may help doctors better understand erectile dysfunction or low testosterone.

Newport Beach, California
NCT07177326Not yet recruiting· Phase 3
Comparing two drug combinations for erectile dysfunction

This study tests two different ways to treat erectile dysfunction (ED): a combination of two commonly used medications (tadalafil and sildenafil) versus a single medication (tadalafil). It aims to see which approach works better and is safe for men with ED.

NCT07642505Recruiting· Phase 4
L-Citrulline and Tadalafil for Mild Erectile Dysfunction

This study tests whether two compounds—L-citrulline (a natural amino acid) and tadalafil (a common erectile dysfunction medication)—work well together for men with mild to moderate erectile problems. The goal is to see if this combination safely improves sexual function.

Banī Suwayf, Beni Suweif Governorate

Hear when a new Erectile Dysfunction, CTCAE trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.